Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 × 109 and 20 × 109 per L

Transfusion

Volumn 47, Issue 5, 2007, Pages 801-812

  Nevo, Shoshan ^a,b   Fuller, Alice K ^a   Hartley, Eric ^a   Borinsky, Mark E ^a   Vogelsang, Georgia B ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NONE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; KERATINOCYTE GROWTH FACTOR; PREDNISONE; THIOTEPA; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLEEDING; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PROPHYLAXIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; WHOLE BODY RADIATION;

ACUTE DISEASE; ADOLESCENT; ADULT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGE; HUMANS; LEUKEMIA; LOGISTIC MODELS; MIDDLE AGED; PLATELET COUNT; PLATELET TRANSFUSION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 34247551886     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01193.x     Document Type: Article

References (47)

1. Platelet transfusion therapy consensus conference. JAMA 1987 257 : 1777 80.
2. Pisciotto PT, Benson K, Hume H, et al. Prophylactic versus therapeutic platelet transfusion practices in hematology and/or oncology patients. Transfusion 1995 35 : 498 502.
3. Murphy MF. State of the art in platelet transfusion therapy. Transfus Sci 1997 17 : 575 84.
4. Patten E. Controversies in transfusion medicine. Prophylactic platelet transfusion revisited after 25 years: con. Transfusion 1992 32 : 381 5.
5. Baer MR, Bloomfield CD. Controversies in transfusion medicine. Prophylactic platelet transfusion therapy: pro. Transfusion 1992 32 : 377 80.
6. Beutler E. Platelet transfusions: the 20,000/microL trigger. Blood 1993 81 : 1411 3.
7. Kelleher JF. When to give platelet transfusions [letter]. Blood 1993 82 : 682.
8. Freireich EJ. When to give platelet transfusions [letter]. Blood 1993 82 : 682 3.
9. Ancliff PJ, Machin JS. Trigger factors for prophylactic platelet transfusion: consensus conference on platelet transfusion. Blood Rev 1998 12 : 234 8.
10. Finazzi G. Prophylactic platelet transfusion in acute leukemia: which threshold should be used. Haematologica 1998 83 : 961 2.
11. Rinder HM, Arbini AA, Snyder EL. Optimal dosing and triggers for prophylactic use of platelet transfusions. Curr Opin Hematol 1999 6 : 437 41.
12. Wandt H, Ehninger G, Gallmeier WM. New strategies for prophylactic platelet transfusion in patients with hematologic diseases. Oncologist 2001 6 : 446 50.
13. Benjamin RJ, Anderson KC. What is the proper threshold for platelet transfusion in patients with chemotherapy-induced thrombocytopenia? Crit Rev Oncol Hematol 2002 42 : 163 71.
14. Corash L. How much do we know about the platelet transfusion threshold? Transfusion 2003 43 : 691 3.
15. Norfolk DR, Ancliffe PJ, Contreras M, et al. Consensus conference on platelet transfusion, Royal College of Physicians of Edinburgh, 27-28 November 1997. Synopsis of background papers. Br J Haematol 1998 101 : 609 17.
16. McCullough J. Current issues with platelet transfusion in patients with cancer. Semin Hematol 2000 37 (2 Suppl 4 3 10.
17. Goodnough LT. Risks of blood transfusion. Anesthesiol Clin North Am 2005 23 : 241 52.
18. Meehan KR, Matias CO, Rathore SS, et al. Platelet transfusions: utilization and associated costs in a tertiary care hospital. Am J Hematol 2000 64 : 251 6.
19. Heckman KD, Weiner GJ, Davis CS, et al. Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL. J Clin Oncol 1997 15 : 1143 9.
20. Rebulla P, Finazzi G, Marangoni F, et al. A multicenter randomized study of the threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. N Engl J Med 1997 337 : 1870 5.
21. Wandt H, Frank M, Ehninger G, et al. Safety and cost effectiveness of a 10x109/L trigger for prophylactic platelet transfusions compared with the traditional 20 × 109/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. Blood 1998 91 : 3601 6.
22. Navarro JT, Hernandez JA, Ribera JM, et al. Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10,000/microL versus 20,000/microL. Haematologica 1998 83 : 998 1000.
23. Lawrence JB, Yomtovian RA, Hammons T, et al. Lowering the prophylactic platelet transfusion threshold: a prospective analysis. Leuk Lymphoma 2001 41 : 67 76.
24. Gil-Fernandez JJ, Alegre A, Fernandez-Villalta MJ, et al. Clinical results of a stringent policy on prophylactic platelet transfusion: non-randomized comparative analysis in 190 bone marrow transplant patients from a single institution. Bone Marrow Transplant 1996 18 : 931 5.
25. Callow CR, Swindell R, Randall W, Chopra R. The frequency of bleeding complications in patients with haematological malignancy following the introduction of a stringent prophylactic platelet transfusion policy. Br J Haematol 2002 118 : 677 82.
26. Zumberg MS, del Rosario ML, Nejame CF, et al. A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000/L versus 20,000/microL trigger. Biol Blood Marrow Transplant 2002 8 : 569 76.
27. Contreras M. Consensus conference on platelet transfusion. Final statement. Blood Rev 1998 12 : 239 40.
28. Schiffer CA, Anderson KC, Bennett CL, et al. American Society of Clinical Oncology. Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001 19 : 1519 38.
29. Stanworth SJ, Hyde C, Heddle N, et al. Prophylactic platelet transfusion for hemorrhage after chemotherapy and stem cell transplantation [review]. Cochrane Database Syst Rev 2004 18 : CD004269.
30. Nevo S, Swan V, Enger C, et al. Acute bleeding after BMT - incidence and effect on survival: a quantitative analysis in 1402 patients. Blood 1998 91 : 1469 77.
31. Field A. In : Discovering statistics using SPSS for windows. London : SAGE Publications 2001.
32. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958 53 : 457.
33. Cox DR, Oakes D. Analysis of survival data. London : Chapman & Hall 1984.
34. Miller CB, Piantadosi S, Vogelsang GB, et al. Impact of age on outcome of patients with cancer undergoing autologous bone marrow transplant. J Clin Oncol 1996 14 : 1327 32.
35. Vamvakas EC. Evidenced based practice of transfusion medicine: is it possible and what do the words mean? Transfus Med Rev 2004 18 : 267 78.
36. Nevo S, Enger C, Hartley E, et al. Thrombocytopenia and acute bleeding after BMT. Bone Marrow Transplant 2001 27 : 65 72.
37. Slichter SJ, Corash L, Schiffer CA, Kickler T. Transfusion medicine - newer approaches to platelet transfusion therapy. In : Hematology education program. American Society of Hematology Orlando, FL 1996.
38. Avvisati G, Tirindelli MC, Annibali O. Thrombocytopenia and hemorrhagic risk in cancer patients. Crit Rev Oncol Hematol 2003 15 (48 Suppl S13 6.
39. Bernstein SH, Nademanee AP, Vose JM, et al. A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation. Blood 1998 1 : 3509 17.
40. Gaydos LA, Freireich EJ, Mantel N. The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. N Engl J Med 1962 266 : 905 9.
41. Slichter SJ, Harker LA. Thrombocytopenia: mechanisms and management. Clin Haematol 1978 7 : 523 9.
42. Gmur J, Burger J, Schanz U, et al. Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia. Lancet 1991 338 : 1223 6.
43. Sagmeister M, Oec L, Gmur J. A restrictive platelet transfusion policy allowing long term support of outpatients with severe aplastic anemia. Blood 1999 93 : 3124 6.
44. Hanson SR, Slichter SJ. Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood 1985 66 : 1105 9.
45. Nevo S, Vogelsang GB. Acute bleeding complications in patients following bone marrow transplantation. Curr Opin Hematol 2001 8 : 319 25.
46. Bacigalupo A. Haemopoietic stem cell transplants: the impact of haemorrhagic complications. Blood Rev 2003 17 (Suppl 1 S6 10.
47. Friedman LM, Furberg CD, DeMets DL. In : Fundamentals of clinical trials. 3rd ed. New York : Springer-Verlag 1998.